Eiger BioPharmaceuticals and AnGes Announce Exclusive Partnership for Regulatory Approval and Commercialization of Zokinvy® (lonafarnib) in Japan
PALO ALTO, Calif. and OSAKA, Japan, May 10, 2022 /PRNewswire/ -- Eiger Biopharmaceuticals Inc. ((", Eiger", , NASDAQ:EIGR) and AnGes Inc. ((", AnGes", , TYO:4563) today announced that the companies entered into an agreement for the regulatory approval, m